EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

Effect of the Xanthine Oxidase Inhibitor Febuxostat on the Cardio-Ankle Vascular Index in Asymptomatic Patients with Hyperuricemia and Liver Dysfunction: A Sub-Analysis of the PRIZE Study

Yusuke Kawachi, Yuya Fujishima, Hitoshi Nishizawa, Atsushi Tanaka, Hisako Yoshida, Shinichi Niwano, Makoto Suzuki, Iichiro Shimomura, Koichi Node

Journal of Atherosclerosis and Thrombosis · 2025

DOI: 10.5551/jat.65087 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2025. Verfasst von Yusuke Kawachi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolic Medicine, Graduate School of Medicine, Osaka University. Hauptthemen laut MEDLINE: Cardio Ankle Vascular Index, Enzyme Inhibitors, Febuxostat, Hyperuricemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardio Ankle Vascular IndexEnzyme InhibitorsFebuxostatHyperuricemiaLiver DiseasesVascular StiffnessXanthine OxidaseAgedFemaleHumansMaleMiddle AgedFollow-Up StudiesGout SuppressantsUric AcidProspective Studies

Stichwörter der Autor:innen

Arterial stiffnessHypertensionHyperuricemiaLiver dysfunctionXanthine oxidoreductase inhibitors

Substanzen

Enzyme InhibitorsFebuxostatGout SuppressantsUric AcidXanthine Oxidase

Autor:innen und Institutionen

  • Department of Metabolic Medicine, Graduate School of Medicine, Osaka University.
  • Department of Metabolism and Atherosclerosis, Graduate School of Medicine, Osaka University.
  • Department of Cardiovascular Medicine, Saga University.
  • Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine.
  • Department of Cardiovascular Medicine, Kitasato University School of Medicine.
  • Department of Cardiology, Yokohama Minami Kyosai Hospital.

Zitieren

APA

Kawachi, Y., Fujishima, Y., Nishizawa, H., Tanaka, A., Yoshida, H., Niwano, S., Suzuki, M., Shimomura, I., & Node, K. (2025). Effect of the Xanthine Oxidase Inhibitor Febuxostat on the Cardio-Ankle Vascular Index in Asymptomatic Patients with Hyperuricemia and Liver Dysfunction: A Sub-Analysis of the PRIZE Study. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.65087

Vancouver

Kawachi Y, Fujishima Y, Nishizawa H, Tanaka A, Yoshida H, Niwano S, et al. Effect of the Xanthine Oxidase Inhibitor Febuxostat on the Cardio-Ankle Vascular Index in Asymptomatic Patients with Hyperuricemia and Liver Dysfunction: A Sub-Analysis of the PRIZE Study. Journal of Atherosclerosis and Thrombosis. 2025. doi:10.5551/jat.65087

BibTeX
@article{Kawachi2025,
  author = {Kawachi, Yusuke and Fujishima, Yuya and Nishizawa, Hitoshi and Tanaka, Atsushi and Yoshida, Hisako and Niwano, Shinichi and Suzuki, Makoto and Shimomura, Iichiro and Node, Koichi},
  title = {Effect of the Xanthine Oxidase Inhibitor Febuxostat on the Cardio-Ankle Vascular Index in Asymptomatic Patients with Hyperuricemia and Liver Dysfunction: A Sub-Analysis of the PRIZE Study},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2025},
  doi = {10.5551/jat.65087}
}
Kostenlos starten →